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Abstract
Purpose Ventriculoatrial (VA) shunts are commonly used as a
second-line treatment of hydrocephalus when the peritoneum
is an unsuitable site for the distal catheter. Many centres now
utilise ultrasound and interventional radiology techniques to
aid placement of the distal catheter. The purpose of this study
was to conduct a contemporary audit of VA shunting in chil-
dren using interventional radiology techniques for placement
of the distal catheter.
Methods A retrospective analysis of all patients who had VA
shunts inserted between June 2000 and June 2010 was con-
ducted using a prospectively updated surgical database and
case notes review.
Results Ninety-four VA shunts were inserted in 38 patients.
Thirty-seven patients had been treated initially with
ventriculoperitoneal (VP) shunts. Twenty-two patients re-
quired at least 1 shunt revision (58 %). The 6-month, 1- and
2-year shunt survival rates were 53, 43 and 27%, respectively.
Blockage was the commonest reason for shunt failure (68 %).
The site of failure was proximal (ventricular catheter +/−
valve) in 32 % and distal (atrial catheter) in 21 % of cases.
The overall infection rate was 6 % per procedure and 11 % per
patient. There were 7 deaths, of which 3 were shunt related.
Conclusions VA shunting provides a viable second-line option
for shunt placement in complex hydrocephalus. The causes of
shunt failure (blockage, infection and equipment failure) are
similar to VP shunting though shunt survival rates are inferior
to VP shunts. Ultrasound guided VA shunt placement provides
a relatively safe, second-line alternative to the placement of a
ventriculoperitoneal shunt when this route is unsuitable.
Keywords Ventriculoatrial . CSF shunt . Hydrocephalus .
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Introduction
Despite the current enthusiasm for endoscopic third
ventriculostomy, ventricular shunting procedures continue to
be the mainstay of hydrocephalus management in children and
ventriculoperitoneal shunting remains the preferred first-line op-
tion. However, approximately 50 % of ventriculoperitoneal
(VP) shunts inserted fail within 2 years [9, 19, 21], with this
figure rising to 85 % after 15 years [22]. The majority of VP
shunts fail due to obstruction, followed by mechanical failures
(migration and disconnection) and infection [22]. Distal shunt
failure may occur as a result of adhesions, intraperitoneal infec-
tion, ascites and cerebrospinal fluid (CSF) pseudocysts [11, 20];
in these situations, an alternative site for the distal catheter may
have to be considered.
Ventriculoatrial shunting (VA) was originally described by
Nulsen and Spitz in 1951 and was the prevailing technique of
hydrocephalus management for many years [15]. In recent
decades, VP shunting has become the preferred treatment
since surgical placement is more straightforward and as VA
shunts can cause serious complications including pulmonary
embolism, pulmonary hypertension [17] and shunt nephritis
[1].
The results of this paper were presented orally at the International Society
of Paediatric Neurosurgery’s Annual Meeting in Goa, October 2011
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Insertion of the atrial catheter was traditionally done through
open dissection of the neck to locate a suitable tributary of the
internal jugular vein (typically the common facial vein) to can-
nulate from whence the catheter could be directed to the right
atrium. This operation could be particularly challenging in the
case of small infants and in cases of revision. Ashker et al. first
described a method for percutaneously inserting the distal cath-
eter in 1981 [2]. Since then, this less invasive method has
gained widespread acceptance but only a few studies have ex-
amined its effect on outcomes in children [5, 6]. We present our
experience of VA shunting with percutaneous insertion of the
distal catheter under ultrasound guidance as a second-line treat-
ment for childhood hydrocephalus over a 10-year period.
Materials and methods
This retrospective study was conducted at the Department of
Neurosurgery at Great Ormond Street Hospital for Children in
London. Patients who had their first VA shunt inserted between
the 1st of June 2000 and the 1st of June 2010 were identified
from the unit’s prospectively updated operative database. The
medical records for these patients were studied as was the oper-
ating theatre log. The aetiology of hydrocephalus, age of initial
intervention, age at insertion of the first VP shunt, the number of
VP shunt revisions prior to VA shunt insertion and the time from
first VP shunt insertion to VA shunt insertion as well as the main
reasons for failure of intraperitoneal placement were document-
ed for all patients. Surgical time for VA shunt insertion was also
noted as was the vein of entry for the atrial catheter.
Outcomes from VA shunt placement were then recorded
including perioperative morbidity and mortality, and any in-
fective complications and responsible organisms involved.
The time to first VA shunt revision was calculated, and the
reasons for shunt failure were also described.
Technique of VA shunt placement
The procedure of VA shunt insertion used in this series was
similar to the technique described by Ashker et al. [2]. The
procedure is performed in conjunction with interventional ra-
diology. Having located the internal jugular vein by ultra-
sound, a transverse incision is made just superior to the clav-
icle overlying the vein. Under ultrasound guidance, the inter-
nal jugular vein is punctured with a 21-gauge needle and a
floppy-tipped 0.018-in guide wire is inserted under fluoro-
scopic control. In small children, the guide wire is advanced
through the right atrium to the inferior vena cava to allow
insertion of dilators over the stiff part of the guide wire. In
larger children, the guide wire need only be advanced into the
right atrium. The 0.018-in guide wire is exchanged for a
0.035-in wire, using a coaxial micropuncture introducer sys-
tem (MAK mini access kit, Merit Medical Systems, Jordan,
UT, USA), and a 9-Fr peel-away sheath (Cook Incorporated,
Bloomington, IN, USA) is inserted, after serial dilation if this
is needed. The distance from the neck incision to the mid-
atrium is then measured using intraoperative fluoroscopy
and a silastic atrial C-type shunt catheter is cut to this length.
The shunt catheter is then fed over the guide wire and passed
along the peel-away catheter. The guide wire and peel-away
catheter are then removed leaving the shunt catheter in situ
which is then attached to the proximal shunt system via a
straight connector. A final radiograph is taken on-table to
identify the location of the tip of the atrial catheter.
Results
Baseline characteristics
Forty-one patients had primary VA shunts inserted during the
study period; 3 were excluded due to insufficient data being
available. The children in this study had undergone a mean of
4.3 (SD +/− 4.6) VP shunt revisions prior to VA shunt place-
ment (range 0 to 13). The mean age of children at the time of
initial VP shunt placement was 1 year (range <1 day to
10.1 years). A total of 94 VA shunts were inserted in 38 pa-
tients, an average of 2.5 shunt operations per patient. Twenty-
three (61 %) of the patients were male. Post-haemorrhagic
hydrocephalus (39 %) and myelomeningocele (13 %) were
the most common causes of hydrocephalus; congenital hydro-
cephalus or cases without clear aetiology comprised 24 %
(Table 1).
The causes of peritoneal catheter failure included CSF as-
cites (42 %) which commonly occurred in the context of re-
peated abdominal surgeries and a prior history intrabdominal
sepsis (24%). Adhesions precluding placement of a peritoneal
catheter and pseudocyst formation occurred in 13 and 16 % of
cases, respectively (Table 2).
Perioperative details
Mean age at placement of first VA shunt was 7.6 years (range
0.4 to 19.8—see Fig. 1). The right internal jugular vein was
used for access in the majority of cases (55 %); see Table 3 for
the frequency of other routes. Major perioperative complica-
tions comprised one intraoperative death (1 %) in which a
septic embolus dislodged from the infected distal end of a
shunt causing a fatal pulmonary embolism. With regard to
morbidity, a single patient with a congenital diaphragmatic
hernia and mediastinal distortion received an atrial perforation
during insertion of the distal catheter resulting in a
haemopericardium. Following urgent cardiac surgical repair,
she recovered fully without further incident.
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Postoperative course
Twenty-two patients required at least one shunt revision
(58 %). Of the 94 VA shunts inserted, 33 had not failed at last
follow-up (35.1 %). The mean number of revisions following
VA shunt insertion was 1.5 (range 0 to 9). The 6-month, 1-, 2-
and 3-year shunt survival rates were 53, 43, 27 and 19 %,
respectively. Figure 2 shows the Kaplan-Meier graph of shunt
survival for all the VA shunts inserted. Mean follow up time
was 2.5 (+/− 2.84) years.
The most common reason for revision was shunt blockage
(68 %), followed by infection (10 %); see Fig. 2. There were
four (6 %) cases of mechanical failure, two (3 %) disconnec-
tions and two (3 %) cases of migration of the distal catheter.
There was one case of a child whose shunt was externalised
due to a suspicious mass on the atrial catheter being identified
by echocardiography, but ultimately no organismwas cultured
from the blood or CSF. Out of 38 primary VA shunts inserted,
four shunts became infected (11 %); out of 94 VA shunts
inserted, six shunts became infected (6 %). In total, four pa-
tients (11 %) had shunt infections. Table 4 summarises the
findings on microscopy and culture of cerebrospinal fluid col-
lected. The frequency which each component of the shunt was
revised following failure is shown in Table 5. The most com-
monly revised component was the ventricular catheter (21 %).
Proximal (ventricular catheter and/or valve) dysfunction only
was the cause of shunt failure in 30 cases (32 %), distal cath-
eter dysfunction only in 20 cases (21 %) and there were nine
(10 %) cases where it was unclear which end of the system
was responsible for shunt failure (Fig. 3).
There were seven (18 %) deaths in this cohort at last follow
up; the causes of death are summarised in Table 6. Three (8%)
deaths were related to the patient’s shunt. Therewas a case of a
septic embolus dislodging intraoperatively from an infected
VA shunt in a 7-year-old female causing a fatal pulmonary
embolism (discussed previously). A 12-year-old male had a
cardiorespiratory arrest as a result of blockage of his external
ventricular drain 1 day following externalisation. Finally,
there was a case of an 8-year-old female with acute renal
failure associated with gentamicin, which had been com-
menced to treat coagulase-negative staphylococcal
meningitis.
Discussion
When the peritoneum becomes unsuitable as a site for the
distal catheter in cerebral shunting, opinions vary as to what
constitutes the most appropriate second-line management.
Whilst VA and ventriculopleural are the most commonly con-
sidered alternatives in such a circumstance, it is always pru-
dent to at least consider the option of endoscopic third
ventriculostomy. Whilst the perceived likelihood of success
might be low, the risk of failure might be more acceptable
when considered in the context of VA and ventriculopleural
shunts. Our preference has been to use VA rather than
Table 1 Aetiologies of hydrocephalus
Aetiology of hydrocephalus n (%)
Post-haemorrhagic 15 (39)
Hydrocephalus of unknown aetiology 9 (24)
Myelomeningocele 5 (13)
Tumour 3 (8)
Dandy Walker malformation 2 (5)
Post-meningitic 2 (5)
Benign intracranial hypertension 1 (3)
Crouzon’s syndrome 1 (3)
Table 2 Reasons for intraperitoneal catheter failure




























Fig. 1 Range of ages at which the primary VA shunt was inserted
Table 3 Vein selected for cannulation
Vein used for distal catheter insertion n (%)
Right internal jugular vein 22 (58)
Left internal jugular vein 9 (24)
Right brachiocephalic vein 2 (5)
Left brachiocephalic vein 1 (3)
Unnamed collateral vein in right side of neck 1 (3)
Unknown 6 (16)
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ventriculopleural shunting as second-line management once
the peritoneal route has failed and ETV has been excluded
as a treatment option. The right atrium of the heart is an
established alternative site for the distal catheter and VA
shunts were the preferred management option for childhood
hydrocephalus prior to the introduction of VP shunts. We
report the largest series of children receiving percutaneously
inserted VA shunts published in the literature to date.
Patient demographics
The patients receiving VA shunts in this study had all (with
one exception) previously had VP shunts which had failed. In
a recently published series of 64 patients with VP shunts with
a minimum of 15 years follow-up, the mean number of shunt
revisions per patient following VP shunt insertion was 2.66
[22]. In our study, the mean number of VP shunt revisions
prior to VA shunt insertion was 4.3, suggesting that this cohort
likely represents a particularly complex sub-group of shunted
patients who by virtue of requiring VA shunting have declared
themselves as prone to shunt failure and complications. The
majority of our patients had multiple serious comorbidities,
many present since birth (including several cases of
necrotising enterocolitis of prematurity). The reasons for peri-
toneal failure are typical and reflect the experience from pre-
vious studies [11, 20]. Post-haemorrhagic hydrocephalus and
myelomeningocele together constituted over half the cases,
and these are both conditions in which there is not infrequent-
ly a history of abdominal surgery for other reasons, such as
necrotising enterocolitis and urological reconstruction
procedures.
Operative technique
Our technique is similar to that described by Ashker et al.;
however, assistance from interventional radiology is sought
to identify and cannulate a suitable vein using ultrasound
and confirm distal catheter position using fluoroscopy. In
Fig. 2 Kaplan-Meier curve of shunt survival over time (in years)
Table 4 Cerebrospinal fluid microscopy and culture results
Shunt Microscopy Culture
1 Gram negative rods Enterobacter cloacae
2 Gram positive cocci Coagulase-negative staphylococci
3 Gram positive cocci Staphylococcus aureus
4 Not seen 1. Corynebacterium diphtheria
2. Bacillus sp.
5 Not seen Propionibacterium acnes
6 Not available Not available
Table 5 Revision procedure undertaken following shunt failure
Revision procedure undertaken following shunt failure n (%)
Ventricular catheter revised 20 (21)
Valve revised 6 (7)
Atrial catheter revised 4 (4)
Ventricular catheter and valve revised 4 (4)
Valve and atrial catheter revised 5 (6)
Ventricular and atrial catheter revised 1 (1)
Whole shunt revised 2 (2)
Externalised 12 (13)
Converted to VP 4 (4)
Shunt removed and contralateral EVD placed 1 (1)
Unknown 2 (2)












Reasons for shunt failure
Fig. 3 Reasons for shunt failure
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terms of the route used for venous access, the internal jugular
vein and subclavian vein [5] have previously been used for
percutaneous placement of the distal catheter; shunts were
inserted into both of these veins in this cohort, and we also
report two cases of successful use of the right brachiocephalic
vein.
Shunt failure
Our study is the only large case series of percutaneously
inserted VA shunts used as second-line management for child-
hood hydrocephalus with long-term follow-up published to
date. We are aware of one other such series [5] which
consisted of only seven patients who were followed up for
between 2 and 12 months. In our cohort, shunt survival at
2 years was 27 %. In comparison, level 1 evidence from pro-
spective, randomised controlled trials (Shunt Design Trial,
Hakim-Medos Investigator Group) puts shunt survival at
52 % 2 years following VP shunting [9, 19]. If we compare
our results to the era in which VA shunts were routinely used
as first-line management for childhood hydrocephalus, Fernell
et al. reported a shunt survival rate of approximately 40 % at
2 years in a large retrospective case series of VA shunts
inserted as first-line treatment for childhood hydrocephalus
at two institutions between 1967 and 1983 [7]. As our study
was investigating the use of VA shunting as an alternative
treatment only when first-line management had failed, this
higher rate is to be expected. Dysfunction of the proximal
end of the shunt (ventricular catheter and/or valve) was more
common in our series than dysfunction of the distal catheter,
which is consistent with what is found in VP shunting [21, 22]
and suggests this disparity in shunt survival is a manifestation
of the complexity of this cohort’s hydrocephalus rather than a
reflection of the inadequacy of the atrium as a site for the distal
catheter. The majority of shunt failures were caused by ob-
struction, infection and mechanical failure, which is again
similar to VP shunting. It has been observed in the past that
shunt failure typically takes place in the first year following
VP shunt insertion and failure rates then plateau [22]; in
comparison, our data suggests that VA shunts continue to fail
at a steady rate even after the first year and, as such, long-term
surveillance of these patients should be considered.
Shunt infections
Eleven percent of patients sustained a shunt infection. In pre-
viously reported series, the infection rate per patient in VA
shunts inserted through open neck dissection as first-line man-
agement for childhood hydrocephalus has been reported as
between 4.2 and 11.3 % [7, 14, 24]. One child in our cohort
died of gentamicin-associated acute kidney injury following a
shunt infection.We observed no cases of endocarditis or shunt
nephritis.
Cardiovascular complications
Pulmonary hypertension is an important complication of VA
shunts that we also did not observe. We observed a single case
of intraoperative pulmonary embolus, described below. A lit-
erature review published in 1993 found that post-mortem di-
agnoses of pulmonary embolism and pulmonary hypertension
were made in 59.7 and 6.3 % of patients with VA shunts,
respectively, but a diagnosis was made during life in only
0.4 and 0.3 % of cases, respectively, suggesting these compli-
cations are under-recognised by clinicians [17]. Median time
between shunt placement and the diagnosis of pulmonary hy-
pertension has previously been reported as 16.5 years [10],
which is why we may not have identified any cases in our
study.
Mortality
Seven (18 %) of the children in this series died (including one
child with a high grade glioma), though in only three cases
(8 %) was death related to the shunt. In a similar study to ours,
Tuli et al. retrospectively collected data on all cerebral shunts
inserted over a 10-year period at their institution and observed
a mortality rate of 13.7 % in the 907 children that presented
Table 6 Causes of death
Patient Time from first VA shunt insertion
to death
Cause of death
1 2 months, 24 days Intraoperative septic embolus
2 9 months, 3 days High grade glioma of posterior fossa with leptomeningeal
spread at diagnosis
3 6 months, 9 days Data unavailable
4 4 months, 21 days Cardiac arrest
5 2 years, 5 months, 25 days Data unavailable
6 2 days Cardiac arrest following shunt blockage
7 7 years, 9 months, 10 days Acute renal failure secondary to gentamicin toxicity
Childs Nerv Syst (2016) 32:1219–1225 1223
[23]. This higher mortality rate may be accounted for by the
fact the patients selected for inclusion in our study had already
had an extensive history of failed VP shunts and, as such, were
more likely to have a poorer prognosis compared to a standard
population of patients with hydrocephalus managed with
shunting. Moreover, the mean age of VA shunt placement in
our study was 7.6 years; conversely, five of the seven children
who died were under 1 year of age at the time of their death.
As they required a VA shunt in infancy, it is again likely their
prognosis even prior to shunt insertion was unfavourable.
Intraoperative adverse events
There was a single intraoperative death in this cohort of
94 VA shunt insertions (1 %). This was due to the dis-
lodgement of a septic embolus during externalisation of
an infected shunt resulting in fatal pulmonary embolism.
As such, we recommend cautious manipulation of the dis-
tal shunt system during revision procedures due to the
possibility of embolisation of both infective and non-
infective material. In previously published studies, opera-
tive mortality pertaining to the open technique ranged
from 0 to 2.9 % [16, 24]. In addition, there was a case
of atrial perforation in a child with a congenital cardiac
anomaly. Taken together, this represents a serious compli-
cation rate of 2 %. We believe that, in experienced hands,
the percutaneous technique is superior in terms of risk and
efficacy when compared with open neck dissection.
Alternatives to VA shunting
Other than the peritoneum and atrium, the pleura is also often
used as a site for the distal catheter of a cerebral shunt [12, 18].
The pleural route has been less popular than the heart because
of the risk of pleural effusion and tension hydrothorax [3].
However, the incidence of pleural effusion can be reduced
significantly through the use of new technology valves [12].
The gallbladder has recently been explored as a possible via-
ble alternative, and a recent review found these shunts exhibit
an overall long-term survival of over 60% [8]. Novel methods
of continuing to use the peritoneum despite previous difficulty
have also been conceived, such as laparoscopically assisted
insertion [4, 11] and placement of the catheter in the omental
bursa [13]; four (11 %) of the patients who had VA shunts
inserted during the 10-year period studied at our institution
had them replaced by VP shunts at last follow-up. The pre-
ferred choice of site for the distal catheter if the peritoneum
fails varies between surgeons with sparse evidence to indicate
which route is safest or most efficacious. Randomised con-
trolled trials or prospective cohort studies comparing sites are
needed to guide future practice.
Limitations
This study is limited by its retrospective methodology.
Moreover, the short follow up time of 2.5 years is a major
disadvantage as the serious cardiac and pulmonary compli-
cations of this procedure discussed earlier often occur only
years after insertion. Shunt complications were only re-
corded if they resulted in a revision procedure; therefore,
data on important non-operatively managed complications
(including cases of slit ventricle syndrome) has not been
included. Our small sample size makes it difficult to draw
any definite conclusions from this study, but it is still the
largest series of VA shunts inserted in children using the
modern technique of percutaneous insertion under ultra-
sound guidance reported in the literature to date and as
such provides data on shunt survival and adverse outcomes
against which future audits of second-line hydrocephalus
treatments can be compared.
Conclusion
VA shunts are an effective second-line intervention for chil-
dren with hydrocephalus in whom the peritoneum is no longer
a suitable site for the distal catheter. The percutaneous ultra-
sound guided technique is safe with a serious adverse event
rate of 2 %. However, patients who require second-line shunt
treatments likely represent a sub-group of hydrocephalus pa-
tients at particular risk for ongoing shunt-related morbidity
and patients and their carers need to be aware of this.
Patients with VA shunts require close monitoring for shunt
infections and their associated sequelae, as well as for cardiac
and pulmonary complications. Moreover, shunt failure rates
for VA shunt in this series are high compared with VP shunts.
Proximal catheter failure remains the commonest cause of
malfunction suggesting that it is the underlying complex hy-
drocephalus in our cohort rather than the atrial site of drainage
that was primarily responsible for failure. We believe that the
technique of percutaneous ultrasound guided distal placement
justifiably will continue to have a place in the repertoire of
complex hydrocephalus management.
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